Mark P. Guerin
2020
In 2020, Mark P. Guerin earned a total compensation of $622.1K as Chief Financial Officer at Onconova Therapeutics.
Compensation breakdown
| Bonus | $142,243 |
|---|---|
| Option Awards | $26,219 |
| Salary | $374,816 |
| Stock Awards | $50,364 |
| Other | $28,467 |
| Total | $622,109 |
Guerin received $374.8K in salary, accounting for 60% of the total pay in 2020.
Guerin also received $142.2K in bonus, $26.2K in option awards, $50.4K in stock awards and $28.5K in other compensation.
Rankings
In 2020, Mark P. Guerin's compensation ranked 10,383rd out of 13,090 executives tracked by ExecPay. In other words, Guerin earned more than 20.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,383 out of 13,090 | 21st |
Division Manufacturing | 4,445 out of 5,621 | 21st |
Major group Chemicals And Allied Products | 1,840 out of 2,254 | 18th |
Industry group Drugs | 1,611 out of 1,954 | 18th |
Industry Pharmaceutical Preparations | 1,189 out of 1,459 | 19th |
Source: SEC filing on May 25, 2022.
Guerin's colleagues
We found one more compensation record of an executive who worked with Mark P. Guerin at Onconova Therapeutics in 2020.
2020
Steven Fruchtman
Onconova Therapeutics